Copyright Reports & Markets. All rights reserved.

Global Gene Therapies for Cancer Treatment Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Gene Therapies for Cancer Treatment Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Gene Induced Immunotherapy
      • 1.4.3 Oncolytic Virotherapy
      • 1.4.4 Gene Transfer
    • 1.5 Market by Application
      • 1.5.1 Global Gene Therapies for Cancer Treatment Market Share by Application (2014-2025)
      • 1.5.2 Hospital
      • 1.5.3 Clinic
      • 1.5.4 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Gene Therapies for Cancer Treatment Market Size
    • 2.2 Gene Therapies for Cancer Treatment Growth Trends by Regions
      • 2.2.1 Gene Therapies for Cancer Treatment Market Size by Regions (2014-2025)
      • 2.2.2 Gene Therapies for Cancer Treatment Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Gene Therapies for Cancer Treatment Market Size by Manufacturers
      • 3.1.1 Global Gene Therapies for Cancer Treatment Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Gene Therapies for Cancer Treatment Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Gene Therapies for Cancer Treatment Market Concentration Ratio (CR5 and HHI)
    • 3.2 Gene Therapies for Cancer Treatment Key Players Head office and Area Served
    • 3.3 Key Players Gene Therapies for Cancer Treatment Product/Solution/Service
    • 3.4 Date of Enter into Gene Therapies for Cancer Treatment Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Gene Therapies for Cancer Treatment Market Size by Type (2014-2019)
    • 4.2 Global Gene Therapies for Cancer Treatment Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Gene Therapies for Cancer Treatment Market Size (2014-2019)
    • 5.2 Gene Therapies for Cancer Treatment Key Players in United States
    • 5.3 United States Gene Therapies for Cancer Treatment Market Size by Type
    • 5.4 United States Gene Therapies for Cancer Treatment Market Size by Application

    6 Europe

    • 6.1 Europe Gene Therapies for Cancer Treatment Market Size (2014-2019)
    • 6.2 Gene Therapies for Cancer Treatment Key Players in Europe
    • 6.3 Europe Gene Therapies for Cancer Treatment Market Size by Type
    • 6.4 Europe Gene Therapies for Cancer Treatment Market Size by Application

    7 China

    • 7.1 China Gene Therapies for Cancer Treatment Market Size (2014-2019)
    • 7.2 Gene Therapies for Cancer Treatment Key Players in China
    • 7.3 China Gene Therapies for Cancer Treatment Market Size by Type
    • 7.4 China Gene Therapies for Cancer Treatment Market Size by Application

    8 Japan

    • 8.1 Japan Gene Therapies for Cancer Treatment Market Size (2014-2019)
    • 8.2 Gene Therapies for Cancer Treatment Key Players in Japan
    • 8.3 Japan Gene Therapies for Cancer Treatment Market Size by Type
    • 8.4 Japan Gene Therapies for Cancer Treatment Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Gene Therapies for Cancer Treatment Market Size (2014-2019)
    • 9.2 Gene Therapies for Cancer Treatment Key Players in Southeast Asia
    • 9.3 Southeast Asia Gene Therapies for Cancer Treatment Market Size by Type
    • 9.4 Southeast Asia Gene Therapies for Cancer Treatment Market Size by Application

    10 India

    • 10.1 India Gene Therapies for Cancer Treatment Market Size (2014-2019)
    • 10.2 Gene Therapies for Cancer Treatment Key Players in India
    • 10.3 India Gene Therapies for Cancer Treatment Market Size by Type
    • 10.4 India Gene Therapies for Cancer Treatment Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Gene Therapies for Cancer Treatment Market Size (2014-2019)
    • 11.2 Gene Therapies for Cancer Treatment Key Players in Central & South America
    • 11.3 Central & South America Gene Therapies for Cancer Treatment Market Size by Type
    • 11.4 Central & South America Gene Therapies for Cancer Treatment Market Size by Application

    12 International Players Profiles

    • 12.1 Novartis
      • 12.1.1 Novartis Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Gene Therapies for Cancer Treatment Introduction
      • 12.1.4 Novartis Revenue in Gene Therapies for Cancer Treatment Business (2014-2019)
      • 12.1.5 Novartis Recent Development
    • 12.2 Kite Pharma
      • 12.2.1 Kite Pharma Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Gene Therapies for Cancer Treatment Introduction
      • 12.2.4 Kite Pharma Revenue in Gene Therapies for Cancer Treatment Business (2014-2019)
      • 12.2.5 Kite Pharma Recent Development
    • 12.3 Amgen
      • 12.3.1 Amgen Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Gene Therapies for Cancer Treatment Introduction
      • 12.3.4 Amgen Revenue in Gene Therapies for Cancer Treatment Business (2014-2019)
      • 12.3.5 Amgen Recent Development
    • 12.4 Shanghai Sunway
      • 12.4.1 Shanghai Sunway Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Gene Therapies for Cancer Treatment Introduction
      • 12.4.4 Shanghai Sunway Revenue in Gene Therapies for Cancer Treatment Business (2014-2019)
      • 12.4.5 Shanghai Sunway Recent Development
    • 12.5 Sibiono
      • 12.5.1 Sibiono Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Gene Therapies for Cancer Treatment Introduction
      • 12.5.4 Sibiono Revenue in Gene Therapies for Cancer Treatment Business (2014-2019)
      • 12.5.5 Sibiono Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.
      In the last several years, global market of Gene Therapies for Cancer Treatment developed rapidly, with an average growth rate of 199%. In 2018, global revenue of Gene Therapies for Cancer Treatment is 445 million USD. The rising prevalence rate of cancer has been a huge challenge for the global economies as the disease leads to high rate of mortality and economic losses. The current treatment options available come with many drawbacks such as severe side effects and relapse of cancer. These factors have led to high investment in the R&D for development of various novel therapies with cancer gene therapy being one of the major ones of them.
      The classification of Gene Therapies for Cancer Treatment includes Gene Induced Immunotherapy, Oncolytic Virotherapy, Gene Transfer, and most of Gene Therapies for Cancer Treatment is Gene Induced Immunotherapy, the proportion of Biopsy in 2018 is about 78%.
      ene Therapies for Cancer Treatment is widely used in Hospital, Clinic and other. The most proportion of Gene Therapies for Cancer Treatment is used in Hospital, and the proportion is about 68.3% in 2018.
      In 2018, the global Gene Therapies for Cancer Treatment market size was 1940 million US$ and it is expected to reach 71800 million US$ by the end of 2025, with a CAGR of 67.6% during 2019-2025.

      This report focuses on the global Gene Therapies for Cancer Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Therapies for Cancer Treatment development in United States, Europe and China.

      The key players covered in this study
      Novartis
      Kite Pharma
      Amgen
      Shanghai Sunway
      Sibiono
      ...

      Market segment by Type, the product can be split into
      Gene Induced Immunotherapy
      Oncolytic Virotherapy
      Gene Transfer

      Market segment by Application, split into
      Hospital
      Clinic
      Other

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Gene Therapies for Cancer Treatment status, future forecast, growth opportunity, key market and key players.
      To present the Gene Therapies for Cancer Treatment development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Gene Therapies for Cancer Treatment are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now